Information  X 
Enter a valid email address

JPMorgan Small Co IT (JMI)

  Print      Mail a friend

Monday 02 December, 2019

JPMorgan Small Co IT

AGM Statement

RNS Number : 4022V
JPMorgan Smaller Cos IT PLC
02 December 2019
 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

JPMORGAN SMALLER COMPANIES INVESTMENT TRUST PLC

 

RESULTS OF ANNUAL GENERAL MEETING

2ND DECEMBER 2019

 

 

 

Legal Entity Identifier: 549300PXALXKUMU9JM18

Information disclosed in accordance with LR 9.6.18

 

Following the Annual General Meeting of the Company, which was held today, the Board is pleased to announce that all of the ordinary resolutions put to shareholders were voted on by Poll and passed. The following special business was also voted on by poll and passed which:

 

 

i)          allows the Company to allot new Ordinary Shares up to an aggregate nominal amount of £390,258, representing approximately 10% of the Company's issued Ordinary Share capital at the date of Notice of AGM;

 

ii)         allows the Company to disapply pre-emption rights on allotment of new Ordinary Shares; and

 

iii)        allows the Company to make market purchases of up to 11,699,945 Ordinary Shares, representing 14.99% of the Company's issued share capital.

 

The full text of all the resolutions can be found in the Notice of Annual General Meeting contained in the Annual Report and Financial Statements which is available for viewing at the National Storage Mechanism which can be located at www.morningstar.co.uk/uk/NSM and from the Company's website, www.jpmsmallercompanies.co.uk 

The full results of the poll conducted at today's meeting will shortly be available on the Company's website, www.jpmsmallercompanies.co.uk

 

2nd December 2019

 

For further information, please contact:

 

Lucy Dina

For and on behalf of

JPMorgan Funds Limited - Secretary

020 7742 4000 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
AGMFSWFWEFUSESE

a d v e r t i s e m e n t